
Geriatric Psychiatry Research Update: January 2017
Three new studies offer insights into psychiatric disorders in the elderly.
References:
1. Quarmley M, Moberg PJ, Mechanic-Hamilton D, et al.
2. Bruce ML, Lohman MC, Greenberg RL, et al.
3. Haeberlein SB, et al. Aducanumab 24-month data from Prime: a randomized, double-blind, placebo-controlled phase 1B study in patients with prodromal or mild Alzheimer’s disease. Presented at:
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.